An observational study to assess long-term safety and effectiveness of Golimumab in routine care using the German BIKER registry
Latest Information Update: 23 Jun 2021
At a glance
- Drugs Golimumab (Primary) ; Methotrexate; Tumour necrosis factor inhibitors
- Indications Juvenile rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 05 Jun 2021 Interim results (n=243) presented at the 22nd Annual Congress of the European League Against Rheumatism
- 01 Jul 2020 New trial record
- 06 Jun 2020 Interim Results (n=212) presented at the 21st Annual Congress of the European League Against Rheumatism